Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor

Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor ( Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA )
1 May 2014

Effective use of ibrutinib in the treatment of ABC lymphoma tumours

Dr Louis Staudt - National Cancer Institute, Bethesda, USA
Effective use of ibrutinib in the treatment of ABC lymphoma tumours ( Dr Louis Staudt - National Cancer Institute, Bethesda, USA )
1 May 2014

New drug demonstrates early promise in metastatic breast cancer

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA
New drug demonstrates early promise in metastatic breast cancer ( Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA )
1 May 2014

Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA
Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475 ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )
1 May 2014

Study shows benefits in use of AG-221 in advanced blood cancers

Dr Eytan Stein - Memorial Sloan Kettering Cancer Center, New York, USA
Study shows benefits in use of AG-221 in advanced blood cancers ( Dr Eytan Stein - Memorial Sloan Kettering Cancer Center, New York, USA )
1 May 2014

Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment

Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment ( Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA )
1 May 2014

Promising research on the use of palbociclib in the treatment of breast cancer

Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA
Promising research on the use of palbociclib in the treatment of breast cancer ( Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
1 May 2014

Role of genomics in assessing risk, especially in ovarian cancer

Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA
Role of genomics in assessing risk, especially in ovarian cancer ( Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA )
1 May 2014

Coffee as a preventative measure against liver cancer

Dr Veronica Wendy Setiawan - University of Southern California, Los Angeles, USA
Coffee as a preventative measure against liver cancer ( Dr Veronica Wendy Setiawan - University of Southern California, Los Angeles, USA )
1 May 2014

The relationship between obesity and cancer, and other dietary factors

Dr Walter C. Willett - Harvard School of Public Health, Boston, USA
The relationship between obesity and cancer, and other dietary factors ( Dr Walter C. Willett - Harvard School of Public Health, Boston, USA )
25 Apr 2014

ecancermedicalscience Editor's Choice for April 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for April 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
24 Apr 2014

Targeted Anti-cancer Therapies (TAT) conference roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Targeted Anti-cancer Therapies (TAT) conference roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
22 Apr 2014